Filters

Miquel Nogué Aligué, Joan Carles Galcerán, Romà Bastus Piulats, Javier Martín-Broto, Pablo Maroto Rey, Montserrat Domenech Santasusana, Angels Arcusa Lanza, Joaquim Bellmunt Molins, Catherine Colin, Atika Girard

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2005;7(2):66-73

Full Text

Abstract

Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines.

Ronald Bartzatt

Current topics in medicinal chemistry 2021;20(10):847-854

Full Text

Abstract

Combination chemotherapy following adrenal suppression in androgen- independent prostate cancer.

A Sella, D Flex, M Konichezky, A Sulkes, J Baniel

European urology 2000;38(3):255-8

Full Text

Abstract

Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme.

M A Rosenthal, M L Gruber, J Glass, A Nirenberg, J Finlay, H Hochster, F M Muggia

Journal of neuro-oncology 2000;47(1):59-63

Full Text

Abstract

Advances in prostate cancer chemotherapy: a new era begins.

David C Smith, Kenneth J Pienta

CA: a cancer journal for clinicians 2005;55(5):300-18; quiz 323-5

Free Full Text

Abstract

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II study.

M R Smith, D Kaufman, W Oh, K Guerin, M Seiden, T Makatsoris, J Manola, P W Kantoff

Cancer 2000;89(8):1824-8

Full Text

Abstract

Results: 1 – 15 / 36

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Estramustine""[mesh_terms]

Necessity of re-evaluation of estramustine phosphate sodium (EMP) as a treatment option for first-line monotherapy in advanced prostate cancer.

Current status of cytotoxic chemotherapy in hormone refractory prostate cancer.

Therapeutic options in androgen-independent prostate cancer: building on docetaxel.

The role of chemotherapy in advanced prostate cancer.

The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancer.

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.

Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer.

Treatment options in hormone-refractory prostate cancer: current and future approaches.

Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.

A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer.

Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines.

Combination chemotherapy following adrenal suppression in androgen- independent prostate cancer.

Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme.

Advances in prostate cancer chemotherapy: a new era begins.

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II study.

Results for
""Estramustine""[mesh_terms]